Market Overview:
The global sleep apnea treatment devices market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of sleep apnea, rising awareness about the benefits of treatment devices, and technological advancements in sleep apnea treatment devices. The global sleep apnea treatment devices market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into positive airway pressure (PAP) devices, oxygen therapy devices, oral appliances, and adaptive servo-ventilation (ASV) Devices. PAP Devices are further sub-segmented into standard PAPdevices and bi-level PAPdevices. Oral appliances are further sub-segmented into mandibular advancement splints (MAS) and tongue retaining appliances (TRA). ASV Devices are further sub-segmented into automatic tube compensation ASVdevicesand volume assured pressure regulated ASVDevices .
Product Definition:
Sleep apnea treatment devices are used to help people with sleep apnea breathe better at night. There are a few different types of devices, including nasal CPAP machines, oral appliances, and positional therapy mattresses. These devices help keep the airway open and allow people with sleep apnea to breathe more easily while they sleep.
Positive Airway Pressure (PAP) Devices:
Positive Airway Pressure (PAP) devices are used to treat obstructive sleep apnea by creating a positive airway pressure. The PAP device works on the principle of suction, which is generated through an oral or nasal mask. This device creates a seal around the mouth and nose, thereby preventing snoring and other respiratory issues associated with sleep apnea.
Oxygen Devices:
Oxygen devices and it's usage in sleep apnea treatment market is expected to witness significant growth over the forecast period. Oxygen devices are used for treating obstructive sleep apnea (OSA), which occurs when breathing is restricted during sleep, causing irregularity in sleeping patterns. The main function of these devices is to provide supplemental oxygen to the patient while he/she is sleeping, thus helping them attain normal breathing patterns.
Application Insights:
Based on application, the market is segmented into hospital use, home use, and others. The home use segment held the largest share in 2017 owing to increasing awareness about treatment options other than PAP machines for obstructive sleep apnea among patients. Furthermore, an increase in disposable income has led to an increase in demand for devices such as CPAP machines by patients at their homes.
The hospital segment is expected to be fastest growing market over the forecast period due to a large patient base that requires continuous monitoring during sleep therapy procedures and ongoing research related to effective treatment of OSA with minimal invasive surgeries. In addition, hospitals are focusing on providing better care by equipping clinical staff with necessary skills required while treating OSA patients thereby driving product demand at a faster rate compared to other segments over the forecast period.
Regional Analysis:
North America dominated the global sleep apnea treatment devices market in 2017. The presence of favorable reimbursement policies, increasing prevalence of respiratory disorders, and high awareness levels are some factors attributing to this dominance. In addition, the growing number of clinical studies conducted for developing effective products is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to a large patient pool and rising healthcare expenditure in emerging economies such as India and China. Furthermore, an increase in disposable income will boost demand further due to its cost-effectiveness compared with other treatments available for sleep apnea patients such as surgery or medication therapy alone which costs several times more than ASV devices used for treating obstructive sleep apnea (OSA).
Growth Factors:
- Increasing prevalence of sleep apnea: The global prevalence of sleep apnea is estimated to be around 4-5%. This number is expected to grow as the awareness about the disorder increases.
- Growing geriatric population: The geriatric population (aged 65 years or older) is growing at a rapid pace and is more susceptible to developing sleep apnea. This will drive the demand for sleep apnea treatment devices in the coming years.
- Rising obesity rates: Obesity has been identified as one of the major risk factors for developing obstructive sleep apnea (OSA). As obesity rates continue to rise, so will the demand for effective treatment options for OSA.
- Technological advancements: Sleep apnea treatment devices are constantly evolving with new and innovative technologies being developed every year. This will help improve patient compliance and outcomes, thus driving market growth in the long run .
Scope Of The Report
Report Attributes
Report Details
Report Title
Sleep Apnea Treatment Devices Market Research Report
By Type
Positive Airway Pressure (PAP) Devices, Oxygen Devices, Oral Appliances, Adaptive Servo Ventialtion (ASV) Devices
By Application
Hospital, Home Use, Others
By Companies
ResMed, Phlips Respironics, Fisher & Paykel Healthcare, DeVilbiss Healthcare, Breas, Apex, Weinmann, Teijin Pharma, Curative Medical, Medtronic, Koike Medical, Somnetics International, Nidek Medical India, SLS Medical Technology, BMC Medical, Curative Medical (China), Bejing Kangdu Medical, Shangcha Beyond Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Sleep Apnea Treatment Devices Market Report Segments:
The global Sleep Apnea Treatment Devices market is segmented on the basis of:
Types
Positive Airway Pressure (PAP) Devices, Oxygen Devices, Oral Appliances, Adaptive Servo Ventialtion (ASV) Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Home Use, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- ResMed
- Phlips Respironics
- Fisher & Paykel Healthcare
- DeVilbiss Healthcare
- Breas
- Apex
- Weinmann
- Teijin Pharma
- Curative Medical
- Medtronic
- Koike Medical
- Somnetics International
- Nidek Medical India
- SLS Medical Technology
- BMC Medical
- Curative Medical (China)
- Bejing Kangdu Medical
- Shangcha Beyond Medical
Highlights of The Sleep Apnea Treatment Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Positive Airway Pressure (PAP) Devices
- Oxygen Devices
- Oral Appliances
- Adaptive Servo Ventialtion (ASV) Devices
- By Application:
- Hospital
- Home Use
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Sleep Apnea Treatment Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Sleep apnea treatment devices are medical devices that are used to treat sleep apnea. These devices help people with sleep apnea breathe more easily by providing a continuous air flow through the nose while they sleep.
Some of the major companies in the sleep apnea treatment devices market are ResMed, Phlips Respironics, Fisher & Paykel Healthcare, DeVilbiss Healthcare, Breas, Apex, Weinmann, Teijin Pharma, Curative Medical, Medtronic, Koike Medical, Somnetics International, Nidek Medical India, SLS Medical Technology, BMC Medical, Curative Medical (China), Bejing Kangdu Medical, Shangcha Beyond Medical.
The sleep apnea treatment devices market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Sleep Apnea Treatment Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Sleep Apnea Treatment Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Sleep Apnea Treatment Devices Market - Supply Chain
4.5. Global Sleep Apnea Treatment Devices Market Forecast
4.5.1. Sleep Apnea Treatment Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Sleep Apnea Treatment Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Sleep Apnea Treatment Devices Market Absolute $ Opportunity
5. Global Sleep Apnea Treatment Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Sleep Apnea Treatment Devices Market Size and Volume Forecast by Type
5.3.1. Positive Airway Pressure (PAP) Devices
5.3.2. Oxygen Devices
5.3.3. Oral Appliances
5.3.4. Adaptive Servo Ventialtion (ASV) Devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Sleep Apnea Treatment Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Sleep Apnea Treatment Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Home Use
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Sleep Apnea Treatment Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Sleep Apnea Treatment Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Sleep Apnea Treatment Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Sleep Apnea Treatment Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Sleep Apnea Treatment Devices Demand Share Forecast, 2019-2026
9. North America Sleep Apnea Treatment Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Sleep Apnea Treatment Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Sleep Apnea Treatment Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Home Use
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Sleep Apnea Treatment Devices Market Size and Volume Forecast by Type
9.7.1. Positive Airway Pressure (PAP) Devices
9.7.2. Oxygen Devices
9.7.3. Oral Appliances
9.7.4. Adaptive Servo Ventialtion (ASV) Devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Sleep Apnea Treatment Devices Demand Share Forecast, 2019-2026
10. Latin America Sleep Apnea Treatment Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Sleep Apnea Treatment Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Sleep Apnea Treatment Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Home Use
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Sleep Apnea Treatment Devices Market Size and Volume Forecast by Type
10.7.1. Positive Airway Pressure (PAP) Devices
10.7.2. Oxygen Devices
10.7.3. Oral Appliances
10.7.4. Adaptive Servo Ventialtion (ASV) Devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Sleep Apnea Treatment Devices Demand Share Forecast, 2019-2026
11. Europe Sleep Apnea Treatment Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Sleep Apnea Treatment Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Sleep Apnea Treatment Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Home Use
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Sleep Apnea Treatment Devices Market Size and Volume Forecast by Type
11.7.1. Positive Airway Pressure (PAP) Devices
11.7.2. Oxygen Devices
11.7.3. Oral Appliances
11.7.4. Adaptive Servo Venialtion (ASV) Devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Sleep Apnea Treatment Devices Demand Share, 2019-2026
12. Asia Pacific Sleep Apnea Treatment Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Sleep Apnea Treatment Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Sleep Apnea Treatment Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Home Use
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Sleep Apnea Treatment Devices Market Size and Volume Forecast by Type
12.7.1. Positive Airway Pressure (PAP) Devices
12.7.2. Oxygen Devices
12.7.3. Oral Appliances
12.7.4. Adaptive Servo Ventialtion (ASV) Devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Sleep Apnea Treatment Devices Demand Share, 2019-2026
13. Middle East & Africa Sleep Apnea Treatment Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Sleep Apnea Treatment Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Sleep Apnea Treatment Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Home Use
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Sleep Apnea Treatment Devices Market Size and Volume Forecast by Type
13.7.1. Positive Airway Pressure (PAP) Devices
13.7.2. Oxygen Devices
13.7.3. Oral Appliances
13.7.4. Adaptive Servo Ventialtion (ASV) Devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Sleep Apnea Treatment Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Sleep Apnea Treatment Devices Market: Market Share Analysis
14.2. Sleep Apnea Treatment Devices Distributors and Customers
14.3. Sleep Apnea Treatment Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. ResMed
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Phlips Respironics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Fisher & Paykel Healthcare
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DeVilbiss Healthcare
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Breas
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Apex
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Weinmann
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Teijin Pharma
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Curative Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Medtronic
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Koike Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Somnetics International
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Nidek Medical India
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. SLS Medical Technology
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. BMC Medical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Curative Medical (China)
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Bejing Kangdu Medical
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Shangcha Beyond Medical
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
